Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
hypoxia-inducible factor 1 alpha subunit | 2 | 0 | 0 | 2 |
RAR-related orphan receptor gamma | 3 | 0 | 0 | 3 |
GLI family zinc finger 3 | 3 | 0 | 0 | 3 |
AR protein | 7 | 0 | 0 | 7 |
aldehyde dehydrogenase 1 family, member A1 | 2 | 0 | 0 | 2 |
retinoic acid nuclear receptor alpha variant 1 | 5 | 0 | 0 | 5 |
retinoid X nuclear receptor alpha | 2 | 0 | 0 | 2 |
estrogen nuclear receptor alpha | 7 | 0 | 0 | 7 |
peroxisome proliferator-activated receptor delta | 1 | 0 | 0 | 1 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 2 | 0 | 0 | 2 |
activating transcription factor 6 | 1 | 0 | 0 | 1 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 2 | 0 | 0 | 2 |
Histone H2A.x | 1 | 0 | 0 | 1 |
thyroid hormone receptor beta isoform a | 2 | 0 | 0 | 2 |
heat shock protein beta-1 | 1 | 0 | 0 | 1 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 3 | 0 | 0 | 3 |
lamin isoform A-delta10 | 2 | 0 | 0 | 2 |
Voltage-dependent calcium channel gamma-2 subunit | 1 | 0 | 0 | 1 |
Glutamate receptor 2 | 1 | 0 | 0 | 1 |
Protein skinhead-1 | 0 | 1 | 0 | 1 |
Monocarboxylate transporter 2 | 0 | 3 | 0 | 3 |
Solute carrier family 22 member 20 | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 6 | 0 | 2 | 0 | 2 |
Monocarboxylate transporter 4 | 0 | 0 | 0 | 2 |
glucocorticoid receptor [Homo sapiens] | 4 | 0 | 0 | 4 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 2 | 0 | 0 | 2 |
geminin | 3 | 0 | 0 | 3 |
Sex hormone-binding globulin | 0 | 0 | 1 | 1 |
Corticosteroid-binding globulin | 0 | 1 | 0 | 1 |
Mineralocorticoid receptor | 0 | 1 | 2 | 3 |
Androgen receptor | 0 | 3 | 0 | 3 |
Mineralocorticoid receptor | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1A1 | 0 | 0 | 0 | 1 |
Guanine nucleotide-binding protein G | 1 | 0 | 0 | 1 |
TDP1 protein | 2 | 0 | 0 | 2 |
peroxisome proliferator activated receptor gamma | 1 | 0 | 0 | 1 |
ATP-binding cassette sub-family C member 3 | 0 | 4 | 0 | 4 |
Multidrug resistance-associated protein 4 | 0 | 4 | 0 | 5 |
Bile salt export pump | 0 | 4 | 0 | 4 |
Cellular tumor antigen p53 | 2 | 0 | 0 | 2 |
Thromboxane-A synthase | 0 | 1 | 0 | 1 |
Prostaglandin E2 receptor EP3 subtype | 0 | 1 | 0 | 1 |
Prostaglandin E2 receptor EP4 subtype | 0 | 1 | 1 | 2 |
Prostaglandin E2 receptor EP1 subtype | 0 | 1 | 0 | 1 |
Prostacyclin receptor | 0 | 1 | 1 | 2 |
Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
Solute carrier organic anion transporter family member 2A1 | 0 | 1 | 0 | 2 |
Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
Prostaglandin E2 receptor EP2 subtype | 0 | 1 | 1 | 2 |
Canalicular multispecific organic anion transporter 1 | 0 | 4 | 0 | 4 |
Solute carrier organic anion transporter family member 2A1 | 0 | 1 | 0 | 2 |
Solute carrier organic anion transporter family member 2B1 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 3A1 | 0 | 0 | 0 | 1 |
thioredoxin reductase | 1 | 0 | 0 | 1 |
ATAD5 protein, partial | 1 | 0 | 0 | 1 |
Microtubule-associated protein tau | 1 | 0 | 0 | 1 |
estrogen-related nuclear receptor alpha | 4 | 0 | 0 | 4 |
arylsulfatase A | 1 | 0 | 0 | 1 |
euchromatic histone-lysine N-methyltransferase 2 | 1 | 0 | 0 | 1 |
Bloom syndrome protein isoform 1 | 1 | 0 | 0 | 1 |
D(1A) dopamine receptor | 1 | 0 | 0 | 1 |
neuropeptide S receptor isoform A | 1 | 0 | 0 | 1 |
Atrial natriuretic peptide receptor 1 | 0 | 0 | 1 | 1 |
Atrial natriuretic peptide receptor 1 | 0 | 0 | 1 | 1 |
estrogen receptor 2 (ER beta) | 2 | 0 | 0 | 2 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 3 | 0 | 0 | 3 |
EWS/FLI fusion protein | 1 | 0 | 0 | 1 |
farnesoid X nuclear receptor | 1 | 0 | 0 | 1 |
aryl hydrocarbon receptor | 1 | 0 | 0 | 1 |
thyrotropin-releasing hormone receptor | 1 | 0 | 0 | 1 |
thyroid hormone receptor beta isoform 2 | 2 | 0 | 0 | 2 |
Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 12 | 0 | 1 | 0 | 3 |
Bile salt export pump | 0 | 1 | 0 | 1 |
Carbonic anhydrase 1 | 0 | 1 | 0 | 3 |
Carbonic anhydrase 2 | 0 | 1 | 0 | 3 |
Albumin | 0 | 1 | 0 | 1 |
Carbonic anhydrase 3 | 0 | 1 | 0 | 2 |
Glucose-6-phosphate 1-dehydrogenase | 0 | 1 | 0 | 1 |
Cytochrome P450 2C9 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 4 | 0 | 1 | 0 | 3 |
Carbonic anhydrase 6 | 0 | 1 | 0 | 3 |
Serum paraoxonase/arylesterase 1 | 0 | 1 | 0 | 1 |
Corticosteroid 11-beta-dehydrogenase isozyme 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 5A, mitochondrial | 0 | 1 | 0 | 3 |
Carbonic anhydrase 7 | 0 | 1 | 0 | 3 |
Adenosine receptor A1 | 0 | 1 | 0 | 1 |
Corticosteroid 11-beta-dehydrogenase isozyme 1 | 0 | 1 | 0 | 1 |
Cytochrome P450 2J2 | 0 | 1 | 0 | 1 |
6-phosphogluconate dehydrogenase, decarboxylating | 0 | 1 | 0 | 1 |
Spike glycoprotein | 1 | 0 | 0 | 1 |
Holo-[acyl-carrier-protein] synthase | 0 | 1 | 0 | 1 |
Sodium/bile acid cotransporter | 0 | 1 | 0 | 1 |
Carbonic anhydrase 9 | 0 | 1 | 0 | 3 |
Multidrug and toxin extrusion protein 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 13 | 0 | 1 | 0 | 3 |
G-protein coupled receptor 35 | 0 | 1 | 1 | 2 |
CDGSH iron-sulfur domain-containing protein 1 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 14 | 0 | 1 | 0 | 3 |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 5B, mitochondrial | 0 | 1 | 0 | 3 |
acetylcholinesterase | 2 | 0 | 0 | 2 |
cytochrome P450 2D6 | 1 | 0 | 0 | 1 |
thyroid stimulating hormone receptor | 1 | 0 | 0 | 1 |
cellular tumor antigen p53 isoform a | 1 | 0 | 0 | 1 |
Integrin beta-3 | 1 | 0 | 0 | 1 |
Integrin alpha-IIb | 1 | 0 | 0 | 1 |
PPM1D protein | 1 | 0 | 0 | 1 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 1 | 0 | 0 | 1 |
progesterone receptor | 3 | 0 | 0 | 3 |
nonstructural protein 1 | 1 | 0 | 0 | 1 |
pregnane X nuclear receptor | 2 | 0 | 0 | 2 |
G | 2 | 0 | 0 | 2 |
bromodomain adjacent to zinc finger domain 2B | 1 | 0 | 0 | 1 |
IDH1 | 1 | 0 | 0 | 1 |
nuclear receptor subfamily 1, group I, member 2 | 2 | 0 | 0 | 2 |
muscleblind-like protein 1 isoform 1 | 1 | 0 | 0 | 1 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
Interferon beta | 2 | 0 | 0 | 2 |
HLA class I histocompatibility antigen, B alpha chain | 2 | 0 | 0 | 2 |
Glucocorticoid receptor | 0 | 2 | 0 | 2 |
Glycine receptor subunit alpha-1 | 0 | 2 | 0 | 2 |
Glycine receptor subunit beta | 0 | 2 | 0 | 2 |
Glycine receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
Glycine receptor subunit alpha-3 | 0 | 2 | 0 | 2 |
Inositol hexakisphosphate kinase 1 | 2 | 0 | 0 | 2 |
ATPase family AAA domain-containing protein 5 | 1 | 0 | 0 | 1 |
Ataxin-2 | 1 | 0 | 0 | 1 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
cytochrome P450 2C9, partial | 2 | 0 | 0 | 2 |
ATP-dependent phosphofructokinase | 1 | 0 | 0 | 1 |
Monocarboxylate transporter 2 | 0 | 0 | 0 | 1 |
Monocarboxylate transporter 1 | 0 | 0 | 0 | 1 |
C-terminal-binding protein 2 | 0 | 1 | 0 | 1 |
Prolyl 4-hydroxylase | 0 | 1 | 0 | 1 |
Alpha-ketoglutarate-dependent dioxygenase FTO | 0 | 1 | 0 | 1 |
nuclear receptor subfamily 1, group I, member 3 | 1 | 0 | 0 | 1 |
potassium voltage-gated channel subfamily H member 2 isoform d | 1 | 0 | 0 | 1 |
cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |